Endonovo Therapeutics, Inc. (ENDV) .
本页证实的标准:
SharesGrow 综合评分： 13/100 其中 0/7 项标准通过。
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-0.05 | $0.00 | $-5.32M | - |
| 2017 | $-0.04 | $0.00 | $-10.81M | - |
| 2018 | $-17.76 | $83.26K | $-6.44M | -7729.5% |
| 2019 | $-33.56 | $310.16K | $-23.4M | -7545.9% |
| 2020 | $-0.17 | $165.8K | $-2.03M | -1222.3% |
| 2021 | $-0.07 | $73.11K | $-4.05M | -5535.1% |
| 2022 | $-0.23 | $135.36K | $-32.14M | -23743.8% |
| 2023 | $0.01 | $140.24K | $6.92M | 4937.6% |
| 2024 | $-0.01 | $10.04K | $-2.8M | -27853.2% |
| 2025 | $0.00 | $0.00 | $-2.18M | - |
